308 related articles for article (PubMed ID: 24040201)
41. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
Lee JH; Kim YG; Lee J
Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of biofilm- and hyphal- development, two virulent features of Candida albicans by secondary metabolites of an endophytic fungus Alternaria tenuissima having broad spectrum antifungal potential.
Chatterjee S; Ghosh R; Mandal NC
Microbiol Res; 2020 Feb; 232():126386. PubMed ID: 31816593
[TBL] [Abstract][Full Text] [Related]
43. The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting.
Jadhav A; Mortale S; Halbandge S; Jangid P; Patil R; Gade W; Kharat K; Karuppayil SM
J Med Food; 2017 Nov; 20(11):1083-1090. PubMed ID: 28922057
[TBL] [Abstract][Full Text] [Related]
44. Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans.
Routh MM; Chauhan NM; Karuppayil SM
Braz J Microbiol; 2013; 44(3):855-9. PubMed ID: 24516452
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
[TBL] [Abstract][Full Text] [Related]
46. Sch9 kinase integrates hypoxia and CO2 sensing to suppress hyphal morphogenesis in Candida albicans.
Stichternoth C; Fraund A; Setiadi E; Giasson L; Vecchiarelli A; Ernst JF
Eukaryot Cell; 2011 Apr; 10(4):502-11. PubMed ID: 21335533
[TBL] [Abstract][Full Text] [Related]
47. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
Aydın C; Ataoğlu H
Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
[TBL] [Abstract][Full Text] [Related]
48. Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis.
Bar-Yosef H; Vivanco Gonzalez N; Ben-Aroya S; Kron SJ; Kornitzer D
Sci Rep; 2017 Jul; 7(1):5692. PubMed ID: 28720834
[TBL] [Abstract][Full Text] [Related]
49. Two new triterpenoid saponins from Gymnema sylvestre.
Zhu XM; Xie P; Di YT; Peng SL; Ding LS; Wang MK
J Integr Plant Biol; 2008 May; 50(5):589-92. PubMed ID: 18713427
[TBL] [Abstract][Full Text] [Related]
50.
Kim H; Hwang JY; Chung B; Cho E; Bae S; Shin J; Oh KB
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30813382
[TBL] [Abstract][Full Text] [Related]
51. Subunits of the vacuolar H+-ATPase complex, Vma4 and Vma10, are essential for virulence and represent potential drug targets in Candida albicans.
Kim SW; Park YK; Joo YJ; Chun YJ; Hwang JY; Baek JH; Kim J
Fungal Biol; 2019 Oct; 123(10):709-722. PubMed ID: 31542189
[TBL] [Abstract][Full Text] [Related]
52. 2-dodecanol (decyl methyl carbinol) inhibits hyphal formation and SIR2 expression in C. albicans.
Lim CS; Wong WF; Rosli R; Ng KP; Seow HF; Chong PP
J Basic Microbiol; 2009 Dec; 49(6):579-83. PubMed ID: 19810039
[TBL] [Abstract][Full Text] [Related]
53. E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.
Watanabe NA; Miyazaki M; Horii T; Sagane K; Tsukahara K; Hata K
Antimicrob Agents Chemother; 2012 Feb; 56(2):960-71. PubMed ID: 22143530
[TBL] [Abstract][Full Text] [Related]
54.
Romo JA; Pierce CG; Esqueda M; Hung CY; Saville SP; Lopez-Ribot JL
Front Cell Infect Microbiol; 2018; 8():227. PubMed ID: 30042929
[TBL] [Abstract][Full Text] [Related]
55. A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion.
Garcia C; Burgain A; Chaillot J; Pic É; Khemiri I; Sellam A
Sci Rep; 2018 Aug; 8(1):11559. PubMed ID: 30068935
[TBL] [Abstract][Full Text] [Related]
56. In vivo anti-ulcer, anti-stress, anti-allergic, and functional properties of gymnemic acid isolated from Gymnema sylvestre R Br.
Arun LB; Arunachalam AM; Arunachalam KD; Annamalai SK; Kumar KA
BMC Complement Altern Med; 2014 Feb; 14():70. PubMed ID: 24559073
[TBL] [Abstract][Full Text] [Related]
57. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages.
Uwamahoro N; Verma-Gaur J; Shen HH; Qu Y; Lewis R; Lu J; Bambery K; Masters SL; Vince JE; Naderer T; Traven A
mBio; 2014 Mar; 5(2):e00003-14. PubMed ID: 24667705
[TBL] [Abstract][Full Text] [Related]
58. Epithelial invasion outcompetes hypha development during Candida albicans infection as revealed by an image-based systems biology approach.
Mech F; Wilson D; Lehnert T; Hube B; Thilo Figge M
Cytometry A; 2014 Feb; 85(2):126-39. PubMed ID: 24259441
[TBL] [Abstract][Full Text] [Related]
59. Phenylpropanoids of plant origin as inhibitors of biofilm formation by Candida albicans.
Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
J Microbiol Biotechnol; 2014 Sep; 24(9):1216-25. PubMed ID: 24851813
[TBL] [Abstract][Full Text] [Related]
60. Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans.
Toenjes KA; Munsee SM; Ibrahim AS; Jeffrey R; Edwards JE; Johnson DI
Antimicrob Agents Chemother; 2005 Mar; 49(3):963-72. PubMed ID: 15728890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
